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1. Introduction  
Marine derived microorganisms especially fungi have the 
potential to produce compounds with high chemical 
diversity.1 Some of them often produce different types of 
secondary metabolites just by the alteration of easily 
accessible cultivation parameters, which was termed OSMAC 
(One Strain-MAny Compounds) approach, proved to be a 
very successful strategy for finding novel secondary 
metabolites.2 In the course of our continuous search for new 
bioactive secondary metabolites from marine derived fungi, 
several new sorbicillinoids have been isolated from the fungus 
strain Penicillium terrestre.3 Different culture conditions 
guided by the OSMAC approach dramatically changed the 
secondary metabolites of this strain which led to the isolation 
of thirteen cytotoxic gentisyl alcohol derivatives.4 
Interestingly, most of them were chlorinated which revealed 
that alternative culture conditions may have activated the 
halogenase enzyme and led to more halogenated compounds. 
Further investigation of the extract again resulted in the 
isolation of two novel chlorinated sorbicillinoids named 
chloctanspirones A (1) and B (2), possessing an 
unprecedented bicyclo[2.2.2]octane-2-spiro cyclohexane 
skeleton. In addition, their quasi-precursors terrestrols K (3) 
and L (4), two additional new chlorinated compounds, were 
also isolated parallel. Up to now, chloctanspirones A (1) and 
B (2) are the first examples of sorbicillinoids containing spiro 
cyclohexane moieties and chlorinated sorbicillinoids have not 
been reported yet. This paper describes the isolation and 
structural elucidation of the new compounds together with a 
tentative biosynthetic route of 1 and 2.  
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Two novel chlorinated sorbicillinoids named chloctanspirones A (1) and B (2), possessing an 
unprecedented bicyclo[2.2.2]octane-2-spiro cyclohexane skeleton, together with their quasi-
precursors terrestrols K (3) and L (4), two additional new chlorinated compounds, were isolated 
from a marine sediment derived fungus Penicillium terrestre. Their structures including 
absolute stereochemistries were elucidated by analysis of NMR, MS data and TDDFT CD 
calculations.  The cytotoxic effects of 1-4 were preliminarily evaluated in HL-60 and A-549 
cells. Compound 1 was active against both HL-60 and A-549 cells with IC50s 9.2 and 39.7 µM 
respectively, while 2 showed weaker activity only against HL-60 cells (IC50 37.8 µM).  
2009 Elsevier Ltd. All rights reserved.
 
O
HO O OH
OHO
HO Cl
O
HO
HO
Cl
1
3
5
7
terrestrol K (3): (5S,6R)
terrestrol L (4): (5R,6S)
chloctanspirone A (1): (19R)
chloctanspirone B (2): (19S)
1
2
3
9
14
5
6
7
8
15
17
19
4
6
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Tetrahedron 2 
 
 
 
 
 
Figure 1. Structures of compounds 1-4. 
 
2. Results and Discussion 
The fungus was cultured and extracted as disclosed in the 
previous report.4 The active crude extract was fractionated by 
using silica gel column chromatography followed by 
chromatography on Sephadex LH20 and finally purified by 
preparative HPLC column to give 1 (13.6 mg), 2 (13.1 mg), 3 
(10.3 mg) and 4 (4.9 mg). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. a) COSY and key HMBC correlations of 1. b) Relevant NOE 
correlations of 1 and 2 and corresponding interatomic distances in the lowest-
energy DFT-optimized conformer of 1. 
 
Chloctanspirone A (1) was obtained as a yellow powder. The 
negative LRESIMS exhibited a characteristic chlorinated quasi-
molecular ion peak cluster at m/z 421/423 (3:1) ([M – H]–), and 
its molecular formula was determined as C21H23O7Cl by 
HRESIMS, which was in agreement with its 1H and 13C NMR 
data. 1D NMR data showed the presence of three sp3 hybridized 
methine groups, two of them attached to oxygen, five sp2 
hybridized methine groups, one methylene group, one allylic 
methyl group, two methyl groups attached to quaternary carbons, 
and nine quaternary carbons.   
 
 
 
 
 
 
 
Figure 3. DFT optimized geometries of the three lowest-energy conformers 
(99.5%) of (1R,4S,5S,8R,18S,19R)-1.  
 
The 1,3-pentadienyl moiety of the sorbyl group from C-10 to 
C-14 was indicated by the characteristic proton chemical shifts 3,5 
at δH 6.41, 7.12, 6.32, 6.21 and 1.84 ppm, which were also 
confirmed by the COSY and HMBC spectra (Table 1). The E 
configurations of the two double bonds in the sorbyl residue was 
determined via the large coupling constants (3J12,13 = 15.1 Hz, 
3J10,11 = 14.6 Hz)  observed. The presence of bicyclo[2.2.2]octane 
moiety was suggested by the comparison of 1D NMR data of 1 
with those of known sorbicillin derivatives 5,6 and confirmed by 
the HMBC correlations from H-4 (δH = 3.49 ppm) to C-2 (δC = 
198.3 ppm), C-3 (δC = 109.3 ppm), C-5 (δC = 74.8 ppm), C-6 (δC 
= 210.2 ppm), C-7 (δC = 38.0 ppm) and C-8 (δC = 57.6 ppm), and 
from H-7 (δH = 1.75, 2.57 ppm) to C-1 (δC = 59.4 ppm), C-2, C-4 
(δC = 45.2 ppm), C-6 and C-8. The positions of CH3-1, CH3-5 
and OH-5 were assigned according to the HMBC correlations 
between CH3-1 (δH = 1.10 ppm) and C-1, C-2, C-6 and C-7, 
between CH3-5 (δH = 1.07 ppm) and C-4, C-5 and C-6, and 
between OH-5 (δH = 6.37 ppm) and C-4, C-5 and C-6. The 
connection of C-3 and C-10 via C-9 was deduced from HMBC 
correlations of OH-9 to C-3 and C-9, and of H-10 to C-3 and C-
9. The dihydroxycyclohexenone moiety was established on the 
basis of COSY correlations (OH-18/H-18/H-19/OH-19) and 
HMBC correlations between OH-18 and C-17, C-18 and C-19, 
between H-17 and C-15, C-16 and C-19, between OH-19 and C-
8, and between H-19 and C-15. With C21H23O7 accounted for, the 
planar structure was determined by introducing the chlorine atom 
to C-16 in accordance with the molecular formula and chemical 
shift of C-16 (δC = 128.3 ppm). Selective gradient NOE data and 
analysis of 3JH,H proton coupling constants were used to 
determine the relative configuration. The bridged ring system is 
only possible if H-4 and CH3-1 are oriented equatorially. NOE 
enhancement of OH-5 was observed by irradiation of H-19 (δH = 
4.66 ppm), showing that OH-5 was oriented towards the 
cyclohexene and C-19 was cis to C-5. With these findings, the 
relative configuration of this part of the molecule was designated 
as (1R*,4S*,5S*,8R*). The NOE enhancements for H-4 and H-18 
upon irradiation of the H-19 resonance, as well as enhancements 
for H-4 and H-19 upon irradiation of the H-18 resonance (δH = 
5.03 ppm) indicated the H-18 and H-19 to be located on the same 
side of cyclohexene and to be oriented towards the sorbyl side 
chain. The cis configuration of H-18 and H-19 was also 
supported by the small coupling constant measured for 3J18,19 (3.2 
Hz). Based on these evidences, the relative configuration of 1 
was proposed as (1R*, 4S*, 5S*, 8R*, 18S*, 19R*). The 
interatomic distances of protons in the lowest-energy conformer 
were all in agreement with the observed NOE effects (Figure 2b). 
The CD spectrum of 1 showed intense positive Cotton Effects 
(CEs) at 356 and 248 nm and negative ones at 306 and 219 nm. 
In order to determine the absolute configuration, the TDDFT CD 
calculations were carried out on the computed solution 
conformers. An MMFF conformational search followed by DFT 
optimization afforded three slightly different conformers (65.4, 
27.2 and 6.9% populations) above 0.5% population (Figure 3). In 
all the three conformers, the OH-19 had axial and the OH-18 had 
equatorial orientation in agreement with the measured coupling 
constants, and OH-5 and OH-9 were hydrogen bonded to 
carbonyl groups. Then the CD spectra of each conformer were 
calculated by various functionals (B3LYP, BH&HLYP, PBE0) 
and TZVP basis set. The Boltzmann-weighted CD spectra of the 
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(1R,4S,5S,8R,18S,19R)-enantiomer reproduced well the 
experimental CD curve with PBE0/TZVP giving the best 
agreement (Figure 4). Thus the absolute configuration of 1 was 
determined unambiguously as (+)-(1R,4S,5S,8R,18S,19R). 
 
Table 1.  NMR data for 1 and 2 (600 and 150 MHz, TMS, δ ppm)
 
1 2 
No. 
δC
a
 δH (J in Hz)a HMBC (H→C)a COSYa δCa δH (J in Hz)a δH (J in Hz)b 
1 59.4 C    59.6 C   
2 198.3 C    198.7 C   
3 109.3 C    109.9 C   
4 45.2 CH 3.49 (1H, s) 2, 3, 5, 6, 7, 8, 9, CH3-5  45.8 CH 3.55 (1H, s) 3.53 (1H, s) 
5 74.8 C    74.3 C   
6 210.2 C    209.8 C   
a: 1.75 (1H, d, 14.0) 1, 2, 6, 8, 15, 19 7b a: 2.04 (1H, d, 14.0) 2.14 (1H, d, 13.7) 
7 38.0 CH2 
b: 2.57 (1H, d, 14.0) 1, 2, 4, 6, 8, 15, CH3-1 7a 
33.8 CH2 
b: 2.44 (1H, d, 14.0) 2.61 (1H, d, 13.7) 
8 57.6 C    57.0 C   
9 166.6 C    166.1 C   
10 118.5 CH 6.41 (1H, d, 14.6) 3, 9, 11, 12 11 118.5 CH 6.42 (1H, d, 14.9) 6.20 (1H, d, 14.6) 
11 141.8 CH 7.12 (1H, dd, 14.6, 10.7) 9 10, 12 141.7 CH 7.11 (1H, dd, 14.9, 11.0) 
7.21 (1H, dd, 14.6, 
11.4) 
12 130.9 CH 6.32 (1H, dd, 15.1, 10.7) 11, 13 11, 13 130.9 CH 6.30 (1H, dd, 15.1, 11.0) 
6.33 (1H, dd, 14.6, 
11.4) 
13 139.1 CH 6.21 (1H, dq, 15.1, 6.4) 11, 12 12, 14 139.1 CH 6.21 (1H, dq, 15.1, 6.4) 
6.16 (1H, dq, 14.6, 
6.6) 
14 18.7 CH3 1.84 (3H, d, 6.4) 12, 13 13 18.7 CH3 1.84 (3H, d, 6.4) 1.88 (3H, d, 6.6) 
15 193.5 C    192.8 C   
16 128.3 C    128.5 C   
17 145.8 CH 6.83 (1H, dd, 2.3, 2.2) 15, 16, 19 19 147.8 CH 7.09 (1H, d, 2.3) 7.08 (1H, d, 2.2) 
18 66.7 CH 5.03 (1H, ddd, 8.3, 3.2, 2.3) 16, 17 18-OH, 19 69.5 CH 4.78 (1H, br. dd, 5.9, 5.4) 4.87 (1H, m) 
19 76.6 CH 4.66 (1H, br.dd, 5.5, 3.2) 15, 17 17, 18, 19-OH 74.1 CH 3.44 (1H, br. dd, 6.9, 5.4) 3.47 (1H, d, 8.4) 
Me-1 12.1 CH3 1.10 (3H, s) 1, 2, 6, 7  12.2 CH3 1.10 (3H, s) 1.21 (3H, s) 
Me-5 24.7 CH3 1.07 (3H, s) 4, 5, 6  25.0 CH3 1.01 (3H, s) 1.13 (3H, s) 
OH-5  6.37 (1H, s) 4, 5, 6   7.29 (1H, s)  
OH-9  13.77 (1H, s) 3, 9   13.68 (1H, s)  
OH-18  5.43 (1H, d, 8.3) 17, 18, 19 18  6.01 (1H, d, 5.9)  
OH-19  5.34 (1H, d, 5.5) 8, 19 19  7.52 (1H, d, 6.9)  
a Recorded in DMSO-d6. b Recorded in CD3OD. 
Table 2. NMR data for 3 and 4 (600 and 150 MHz, TMS, δ ppm) 
3 4 
No. δCa δH (J in Hz) a HMBC (H→C) a COSYa δCa δH (J in Hz) a δH (J in Hz) b 
1 192.6 C    193.0 C   
2 129.6 C    131.2 C    
3 148.7 CH 7.07 (1H, d, 2.3) 1, 2, 5 4 142.7 CH  7.04 (1H, dd, 5.5, 1.4) 6.99 (1H, d, 4.8) 
4 72.3 CH 4.26 (1H, ddd, 8.3, 6.0, 2.3) 2, 5 4-OH, 3, 5 68.0 CH 4.18 (1H, br.dd, 6.0, 5.5) 4.31 (1H, dd, 4.8, 3.3) 
5 76.5 CH 3.32 (1H, ddd, 8.3, 5.5, 2.3) 4 5-OH, 4, 6 74.1 CH 3.82 (1H, m) 3.95 (1H, dd, 3.3, 2.9) 
6 47.8 CH 2.49 (1H, dq, 6.9, 2.3) 1, 4, 5, 7 5, 7 43.4 CH  2.99 (1H, dq, 6.9, 2.7) 3.03 (1H, dq, 7.0, 2.9) 
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7 11.1 CH3 1.11 (3H, d, 6.9) 1, 5, 6 6 11.1 CH3 1.09 (3H, d, 6.9) 1.20 (3H, d, 7.0) 
4-OH  5.76 (1H, d, 6.0) 3, 4 4  5.72 (1H, d, 6.0)  
5-OH  5.61 (1H, d, 5.5) 5, 6 5  5.43 (1H, d, 4.1)  
a
 Recorded in DMSO-d6. b Recorded in CD3OD. 
 
 
 
 
 
 
 
Figure 4. Experimental CD spectrum of 1 in MeOH compared with the 
PBE0/TZVP Boltzmann-weighted spectrum calculated for the three lowest-
energy conformers of the (1R,4S,5S,8R,18S,19R)-enantiomer. Bars indicate 
the calculated rotatory strengths of conformer A. 
 
An accurate mass analysis of 2 showed the same C21H23O7Cl 
molecular formula as that of 1. Its NMR data (Table 1), in 
particular the COSY and HMBC correlations, revealed that 2 and 
1 share the same planar structure implying that they only differ in 
the configuration of chiral centers. NOE enhancement of OH-5 
was observed upon irradiation of OH-19, which showed that the 
C-5 hydroxyl group oriented towards the cyclohexenone moiety 
in 1. Moreover, NOE effects between H-4 and H-18 was also 
indicating that H-18 oriented towards the sorbyl side chain. 
However, the trans relative configuration of H-18 and H-19 was 
suggested by the 8.4 Hz coupling constant of 3J18,19 measured in 
CD3OD, which was accompanied by chemical shift differences of 
C-7, C-18 and C-19. The CD spectrum of 2 was nearly identical 
with that of 1, which proved that the absolute configuration of the 
sorbicillin moiety was the same as that of 1. Therefore compound 
2 is the C-19 epimer of 1 and its absolute configuration was 
determined as (+)-(1R,4S,5S,8R,18S,19S) and named as 
chloctanspirone B. 
Terrestrol K (3) was obtained as an oil. The molecular 
formula (C7H9O3Cl) was determined by NMR data and its 
HRESIMS spectrum showing an [M - H]- peak at m/z 
175.0165. A detailed analysis of the 1H-NMR and 13C-NMR 
data for 3 indicated the presence of one methyl group, four 
methines, two quaternary carbons and two hydroxyl groups 
(Table 2). The COSY experiment readily established the 
carbon skeleton from C-3 to C-7 as well as the positions of 
two hydroxyl groups. Furthermore, the HMBC correlations 
between H-7 and C-1, between H-3 and C-1, and between H-4 
and C-2 completed the planar structure of 3 by the 
connectivity of C-2 to C-6 via C-1. 
 
 
 
 
 
 
 
Figure 5. DFT optimized geometries of the four lowest-energy conformers 
(94.1%) of (4S,5S,6R)-3. The ωO-1,C-1,C-3,C-3 torsional angle of conformers A-D 
are −178.6°, −177.5°, −179.7°, −179.4°, respectively. 
 
The analysis of 3JH,H coupling constants was used to deduce 
the relative configuration. The small coupling constant of 3J3,4 
(2.3 Hz) indicated that the ωH-3,C-3,C-4,H-4 dihedral angle is close to 
90° with an axial H-4. On the other hand, the large coupling 
constant measured for 3J4,5 (8.3 Hz) revealed that H-5 was also 
axial. In addition, the equatorial orientation of H-6 was deduced 
from the small value of the 3J5,6 (2.3 Hz). Thus the relative 
configuration of 3 was determined as (4S*,5S*,6R*). The 
absolute configuration of 3 was established by TDDFT CD 
calculation. Although quite a number of semiempirical rules were 
reported to correlate the stereochemistry of cyclohexenone 
derivatives with characteristic CD bands, the substitution pattern 
of 3 with chirality centers did not allow a safe configurational 
assignment.7,8 Compound 3 showed a positive n-pi* band between 
370 and 290 nm, a positive pi-pi* band (I band) at 245 nm, a 
negative pi-pi* band at 216 nm (II band made up two pi-pi* 
transitions) and a negative pi-pi transition below 200 nm (III 
band).7 An MMFF conformational search of 3 followed by DFT 
optimization afforded four major conformers with 43.5%, 28.8%, 
14.4% and 7.4% populations (Figure 5). In all the four 
conformers, H-4 and H-5 were axial, while H-6 had equatorial 
orientation in accordance with the measured coupling constants. 
The conformers differed mainly in the orientation of the hydroxyl 
protons. The cyclohexenone ring had an envelop conformation 
with C-5 out of the plane (Figure 6) and the enone chromophore 
was nearly planar (ωO-1,C-1,C-3,C-3 torsional angle was close to 
180°). The Boltzmann-weighted average of the CD spectra 
calculated for the four conformers of (4S,5S,6R)-3 with three 
functionals reproduced well the pi-pi* transitions (I-III band). The 
best agreement was obtained with BH&HLYP/TZVP shown in 
Figure 7, which allowed determining the absolute configuration 
of 3 as (+)-(4S,5S,6R) . 
 
 
 
 
Figure 6. a) Schematic representation of the preferred envelop conformation 
of (4S,5S,6R)-3 viewed from the direction of the double bond. b) Preferred 
envelop conformation of (4S,5R,6S)-4. c) Structure of the lowest-energy 
conformer of (4S,5S,6R)-3. 
 
Terrestrol L (4) was obtained as an oil. The HRESIMS of 4 
and NMR data suggested that it was an isomer of 3, with a 
molecular formula of C7H9O3Cl. The comparison of the 1D NMR 
data of 4 (Table 2) with those of 3 afforded the same planar 
structure as 3. The NOESY correlations between CH3-6 and OH-
4, as well as between CH3-6 and OH-5, suggested that CH3-6 and 
OH-4 located on the same side of the ring and they are axial, 
while OH-5 had an equatorial orientation. This was also 
confirmed by the small 3JH,H coupling constant of the methine 
O
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C C C C
HCl H
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 5 
protons measured in CD3OD (3J5,6 = 2.9 Hz, 3J4,5 = 3.3 Hz). Thus 
4 had an all-cis relative configuration, i.e. (4S*,5R*,6S*). The 
CD spectra of 4 showed a negative n-pi* band between 370 and 
290 nm and a positive pi-pi* band at 192 nm (III band), i.e. 
opposite to those of 3. This suggested that the envelop 
conformation (helicity) of the cyclohexenone ring was inverted 
as shown in Figure 6b. By introducing the OH-4 and CH3-6 in 
axial and OH-5 in equatorial position into this conformer, the 
absolute configuration of 4 could be deduced as (+)-(4S,5R,6S). 
 
 
 
 
 
 
 
 
 
Figure 7. Experimental CD spectrum of 3 compared with the 
BH&HLYP/TZVP CD spectrum calculated for the four lowest-energy 
conformers of (4S,5S,6R)-3. Bars indicate the calculated rotatory strengths of 
conformer A (Figure 5). 
 
A possible biosynthetic route to 1 and 2 was proposed (Figure 
8). The methyl groups of the chlorinated precursors 3 and 4 were 
oxidized and with a subsequent dehydration generated a double 
bond was produced. By a Diels-Alder reaction, this exocyclic 
double bond reacted with the diene moiety of the unstable 
intermediate (5S)-sorbicillinols,9 formed from sorbicillin which 
was also isolated from this fungus,to form the spiro carbon C-8. 
The absolute configurations of compounds 1 and 2 were in 
agreement with the precursors (3 for 2 and 4 for 1 respectively). 
The isolation of 3 and 4 indicated that the chlorination step 
preceded the Diels-Alder reaction.  
 
 
 
 
Figure 8. A possible biosynthetic route to chloctanspirones A (1) and B (2) 
 
Most of the reported sorbicillin polymers were produced in the  
addition of two or three sorbicillin derivatives.5,10 Natural Diels-
Alder products of sorbicillinol with a dienophile not related to the 
sorbicillinoids were quite rare in nature, and only a few 
exampleshave been reported.6,11 It is the first case that this kind 
of precursors (3 and 4) have been isolated together with the 
Diels-Alder products (1 and 2). To the best of our knowledge, 1 
and 2 represent the first natural products containing 
bicyclo[2.2.2]octane-2-spirocyclohexenone moiety. 
Table 3. Cytotoxicities of 1-4 on cancer cell lines 
 cytotoxicity (IC50, µM) 
compound HL-60 A-549 
1 9.2 39.7 
2 37.8 >100 
3 >100 >100 
4 >100 >100 
 
The cytotoxicities of 1–4 were preliminarily evaluated in HL-
60 and A-549 cells (Table 3) by the MTT method.4 Compound 1 
was active against both cells with IC50s 9.2 and 39.7 µM 
repectively, while 2 showed weaker activity only against HL-60 
cells (IC50 37.8 µM). Interestingly, the inversion of configuration 
at C-19 affected the activities of 1 and 2 significantly suggesting 
that although the cyclohexenone moiety was not the 
pharmacophore (3 and 4 showed no activities), its 
stereochemistry influenced the observed activity. 
 
3. Experimental Section 
3.1 General Experimental Procedures. Optical rotations were 
obtained on a JASCO P-1020 digital polarimeter. UV spectra 
were recorded on a Beckman DU® 640 spectrophotometer. CD 
spectra were measured on a J-810 CD spectropolarimeter. IR 
spectra were recorded on a NICOLET NEXUS 470 
spectrophotometer in KBr discs. 1H, 13C NMR and DEPT spectra 
and 2D NMR were recorded on a JEOL JNM-ECP 600 
spectrometer and BRUKER AV-400 spectrometer using TMS as 
an internal standard and chemical shifts were recorded as δ 
values. ESIMS were measured on a Q-TOF ULTIMA GLOBAL 
GAA076 LC mass spectrometer. Semipreparative HPLC was 
performed using an ODS column [YMC-pack ODS (A), 10 × 250 
mm, 5 µm, 4 mL/min]. 
3.2 Fungal Material. The fungus P. terrestre was isolated from 
marine sediments collected in Jiaozhou Bay, China. It was 
identified by Professor C. X. Fang, China Center for Type 
Culture Collection (identification number: 2004021), and the 
voucher specimen is preserved in the China Center for Type 
Culture Collection (patent depositary number: CCTCC M 
204077). Working stocks were prepared on Potato Dextrose agar 
slants stored at 4 °C. 
3.3 Fermentation and Extraction. The fungus was cultured 
under static conditions at 24 °C for 30 days in 200 1000-mL 
conical flasks containing the liquid medium (300 mL/flask) 
composed of soytone (0.1%), soluble starch (1.0%), and seawater 
(60%) as descripted previously.4 The fermented whole broth (60 
L) in the modified culture condition was filtered through cheese 
cloth to separate it into supernatant and mycelia. The former was 
extracted three times with EtOAc to give an EtOAc solution and 
concentrated under reduced pressure to give a crude extract (20.0 
g). 
3.4 Purification. The crude extract (20.0 g) was purified by a 
silica gel (200~300 mesh) column packed in petroleum ether. 
The column was eluted by gradient ratios of petroleum ether–
CHCl3 and then with CHCl3–MeOH. The active fraction 
(Inhibitory Rate >50% at a concertration of 100 µg/ml) that was 
eluted with CHCl3–MeOH (50:1) was further separated into three 
subfractions by Sephadex LH-20 using CHCl3–MeOH (1:1) as 
the eluting solvent. Subfraction 1 was further purified by PHPLC 
(62% MeOH, 4.0 mL/min), to give 1 (13.6 mg) and 2 (13.1 mg). 
The active fraction eluted with CHCl3–MeOH (100:1) was 
further separated into four subfractions by Sephadex LH-20 using 
CHCl3–MeOH (1:1) as the eluting solvent. Subfraction 4 was 
O
Cl
HO
HO
O
HO O OH
H
O
HO
HO
Cl
4/3
Sorbicillinol
Diels-Alder
OH
O
O
HO
s
O
HO
HO
Cl
[O] O
HO
HO
Cl
OH
1/2
[-H2O]
Sorbicillin
OH
HO
O
[O]
OH
HO
O
O
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Tetrahedron 6 
subjected to Sephadex LH-20 (CHCl3–MeOH, 1:1), then further 
purified by PHPLC (20% MeOH, 4.0 mL/min) to give 3 (10.3 
mg) and 4 (4.9 mg). 
Chloctanspirone A (1): yellow powder; [α]D +304 (c = 0.1, 
MeOH); ECD (MeOH), λ [nm] (∆ε), c = 1.18 × 10−3): 356 (17.6), 
306 (−22.0), 274sh (−2.8), 248 (15.9), 219 (−7.6); IR (KBr) νmax 
3419, 1735, 1701, 1612 cm-1; UV (MeOH) λmax nm (log ε): 245 
(3.67), 359 (3.98); 1H NMR and 13C NMR data see table 1; 
HRESIMS m/z: 421.1068 [M – H]– (calcd for C21H22O7Cl, 
421.1054). 
Chloctanspirone B (2): yellow powder; [α]D +110 (c = 0.1, 
MeOH); ECD (MeOH), λ [nm] (∆ε), c = 1.18 × 10−3): 362sh 
(24.9), 345 (27.6), 306 (−32.1), 273sh (−3.8), 249 (18.9), 221 
(−10.0); IR (KBr) νmax 3459, 1735, 1700, 1607 cm-1; UV (MeOH) 
λmax nm (log ε): 247 (3.68), 359 (3.97); 1H NMR and 13C NMR 
data see table 1; HRESIMS m/z: 421.1062 [M – H]– (calcd for 
C21H22O7Cl, 421.1054). 
Terrestrol K (3): colorless oil; [α]D +89 (c = 0.1, MeOH); 
ECD (MeOH), λ [nm] (∆ε), c = 2.831 × 10−3): 326 (0.4), 245 
(6.4), 216 (−3.8), 193 (−4.6); IR (KBr) νmax 3360, 1696, 1613 cm-
1; UV (MeOH) λmax nm (log ε): 240 (3.52);  1H NMR and 13C 
NMR data see table 2; HRESIMS m/z: 175.0165 [M - H]- (calcd 
for C7H8O3Cl, 175.0162). 
Terrestrol L (4): colorless oil; [α]D +49 (c = 0.1, MeOH); ECD 
(MeOH), λ [nm] (∆ε), c = 2.831 × 10−3): 311 (−0.3), 248 (5.7), 
220 (−3.5), 192 (1.0); IR (KBr) νmax 3337, 1696, 1612 cm-1; UV 
(MeOH) λmax nm (log ε): 238 (3.54); 1H NMR and 13C NMR data 
see table 2; HRESIMS m/z: 175.0159 [M - H]- (calcd for 
C7H8O3Cl, 175.0162). 
3.5 Biological Assays. Cytotoxic activity was evaluated by the 
MTT method. CDDP (cis-diamminedichloroplatinum) was used 
as positive control. The IC50 values were obtained using the 
Bliss method. 
3.6 Computational Section. Conformational searches were 
carried out by means of the Macromodel 9.7.21112 software using 
Merck Molecular Force Field (MMFF) with implicit solvent 
model for chloroform. In each conformational search the 
maximum number of steps were set to 30000. Geometry 
reoptimizations at B3LYP/6-31G(d) level of theory followed by 
TDDFT calculations using various functionals (B3LYP, 
BH&HLYP, PBE0) and TZVP basis set were performed by the 
Gaussian 0313 package. Boltzman distributions were estimated 
from the ZPVE corrected B3LYP/6-31G(d) energies. CD spectra 
were generated as the sum of Gaussians14 with 3000 cm–1 half-
height width (corresponding to ca. 19 nm at 250 nm), using 
dipole-velocity computed rotational strengths. The MOLEKEL14 
software package was used for visualization of the results. 
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